Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × Alpelisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 45 Neoplasm Metastasis 9 Hereditary Sensory and Autonomic Neuropathies 6 Recurrence 5 Ovarian Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Triple Negative Breast Neoplasms 3 Multiple Endocrine Neoplasia Type 1 3 Lymphangioma 3 Hyperglycemia 3 Head and Neck Neoplasms 3 Pancreatic Neoplasms 2 Lymphatic Abnormalities 2 Lymphangioma, Cystic 2 Head and Neck Squamous Cell Cancer 2 Endometrial Neoplasms 2 Advanced Breast Cancer 2 Vascular Malformations 1 Uveal Melanoma 1 Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein 1 Stomach Neoplasms 1 Solid Tumor 1 Skin Diseases, Vascular 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pre-menopausal Breast Cancer 1 Oropharyngeal Neoplasms 1 Multiple Myeloma 1

Interventions

Fluorouracil 447 Bevacizumab 422 Oxaliplatin 398 Leucovorin 393 Irinotecan 364 Capecitabine 279 Cetuximab 278 pembrolizumab 129 Folfox protocol 118 Panitumumab 100 regorafenib 95 Colonoscopy 76 IFL protocol 73 Nivolumab 70 Drug Therapy 69 trifluridine tipiracil drug combination 62 Radiotherapy 60 HMPL-013 53 Blood Specimen Collection 52 Neoadjuvant Therapy 43 Gemcitabine 43 Specimen Handling 40 Chemotherapy, Adjuvant 39 Biopsy 38 Standard of Care 37 Cyclophosphamide 37 Magnetic Resonance Spectroscopy 36 Surveys and Questionnaires 35 atezolizumab 34 Cisplatin 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04753203 2023-10-31

ALCAP

Korean Cancer Study Group

Phase 1/2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡